Park Place Capital’s Idexx Laboratories IDXX Stock Holding History

Park Place Capital’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$46.3K	Buy	88 +24	+38%	+$13.5K	0.01%	435
2026 Q1	$36K	Buy	64 +21	+49%	+$13.5K	0.01%	399
2025 Q4	$29.1K	Buy	+43	New	+$29.3K	0.01%	409
2025 Q1	–	Sell	-8	Closed	-$3.31K	–	849
2024 Q4	$3.31K	Sell	8 -16	-67%	-$7.02K	﹤0.01%	686
2024 Q3	$12.1K	Sell	24 -21	-47%	-$10.2K	﹤0.01%	588
2024 Q2	$21.9K	Sell	45 -215	-83%	-$108K	0.01%	487
2024 Q1	$140K	Sell	260 -260	-50%	-$142K	0.05%	276
2023 Q4	$289K	Sell	520 -437	-46%	-$205K	0.12%	184
2023 Q3	$418K	Sell	957 -36	-4%	-$18K	0.12%	157
2023 Q2	$499K	Sell	993 -81	-8%	-$38.8K	0.14%	144
2023 Q1	$537K	Sell	1,074 -15	-1%	-$7.18K	0.15%	137
2022 Q4	$444K	Buy	+1,089	New	+$423K	0.13%	156

Other funds holding IDXX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Park Place Capital's IDXX Position: Q2 2026 in Review

Park Place Capital increased its Idexx Laboratories (IDXX) stake by 38% in Q2 2026, buying an estimated $13.5K and bringing the position to 88 shares worth $46.3K. The position accounts for 0.01% of the portfolio, ranked #435.

Park Place Capital first reported a position in IDXX in Q4 2022 and has held it in 12 quarters since. The position peaked at $537K in Q1 2023. 1,295 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

Park Place Capital held 88 shares of Idexx Laboratories worth $46.3K as of Q2 2026.
Park Place Capital bought 24 Idexx Laboratories shares in Q2 2026, an estimated $13.5K.
Idexx Laboratories made up 0.01% of Park Place Capital's portfolio in Q2 2026, its #435 holding.
Park Place Capital first reported a position in Idexx Laboratories in Q4 2022 and has held it in 12 quarters since.
Park Place Capital's Idexx Laboratories position peaked at $537K in Q1 2023.
1,295 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Park Place Capital's 13F filing for Q2 2026, filed 14 Aug 2026.